WILMINGTON, Del., January 27, 2025--AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) has been approved in the US for the treatment of adult patients with unresectable ...
BallerAlert on MSN4mon
HBCU Week Foundation Announces 8th Annual HBCU Week in Wilmington and College Fair at Walt Disney WorldThe HBCU Week Foundation is gearing up for its 8th annual HBCU Week Wilmington (DE), presented by AstraZeneca, running from September 22-29, 2024. In addition to the Wilmington festivities ...
WILMINGTON, Del., January 13, 2025--(BUSINESS WIRE)--AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted and granted ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback